Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China · Delayed Price · Currency is CNY 12.40
+0.05 (0.40%)
Sep 29, 2025, 2:45 PM CST
Aier Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 3,557 | 3,556 | 3,359 | 2,524 | 2,323 | 1,724 | Upgrade |
Depreciation & Amortization | 1,703 | 1,569 | 1,347 | 1,166 | 951.72 | 415.92 | Upgrade |
Other Amortization | 453.54 | 377.82 | 318.3 | 224.17 | 173.07 | 134.45 | Upgrade |
Loss (Gain) From Sale of Assets | -4.41 | -4.27 | -0.71 | 1.25 | -0.05 | -0.93 | Upgrade |
Asset Writedown & Restructuring Costs | 195.52 | 194.52 | 389.72 | 100.34 | 220.94 | 365.93 | Upgrade |
Loss (Gain) From Sale of Investments | -334.08 | -547.62 | 32.9 | 315.49 | 343.61 | 147.23 | Upgrade |
Provision & Write-off of Bad Debts | 11.22 | 116.31 | 107.44 | 77.27 | 97.89 | 90.53 | Upgrade |
Other Operating Activities | 370.14 | 441.84 | 443.31 | 203.62 | 234.42 | 328.99 | Upgrade |
Change in Accounts Receivable | -54.7 | -40.75 | -264.53 | -68.21 | -109.44 | -132.39 | Upgrade |
Change in Inventory | -206.74 | -85.87 | -168.65 | -159.47 | -37.58 | -38.91 | Upgrade |
Change in Accounts Payable | -434.4 | -877.11 | 136.05 | -48.99 | -206.86 | 342.25 | Upgrade |
Change in Other Net Operating Assets | 61.56 | 82.07 | 145.39 | 228.44 | 126.8 | 0.97 | Upgrade |
Operating Cash Flow | 5,440 | 4,882 | 5,872 | 4,491 | 4,084 | 3,344 | Upgrade |
Operating Cash Flow Growth | 1.76% | -16.86% | 30.76% | 9.96% | 22.15% | 60.87% | Upgrade |
Capital Expenditures | -1,771 | -1,830 | -1,460 | -1,388 | -1,494 | -893.71 | Upgrade |
Sale of Property, Plant & Equipment | 8.49 | 5.56 | 5.55 | 7.81 | 6.37 | 5.44 | Upgrade |
Cash Acquisitions | -1,541 | -1,966 | -1,586 | -1,126 | -945.53 | -30.05 | Upgrade |
Divestitures | - | - | - | 0.18 | - | - | Upgrade |
Investment in Securities | 2.29 | 729.12 | -305.88 | -795.67 | -250.32 | -317.18 | Upgrade |
Other Investing Activities | 112.17 | 213.25 | 41.75 | 42.4 | 169.16 | 178.33 | Upgrade |
Investing Cash Flow | -3,189 | -2,848 | -3,304 | -3,260 | -2,514 | -1,057 | Upgrade |
Long-Term Debt Issued | - | 1,506 | 863.31 | 438.21 | 720.32 | 2,610 | Upgrade |
Long-Term Debt Repaid | - | -1,870 | -1,422 | -2,350 | -1,170 | -3,045 | Upgrade |
Net Debt Issued (Repaid) | -306.43 | -364.64 | -559.03 | -1,912 | -449.79 | -435.2 | Upgrade |
Issuance of Common Stock | - | - | - | 3,852 | 1,296 | 693.12 | Upgrade |
Repurchase of Common Stock | -8.23 | -46.36 | -576.16 | -5.1 | -3.18 | -2.13 | Upgrade |
Common Dividends Paid | -1,569 | -1,419 | -746.9 | -672.56 | -662.5 | -530.73 | Upgrade |
Other Financing Activities | -553.85 | -903.55 | -627.63 | -872.55 | -420.08 | -576.68 | Upgrade |
Financing Cash Flow | -2,437 | -2,734 | -2,510 | 390.43 | -239.62 | -851.62 | Upgrade |
Foreign Exchange Rate Adjustments | -17.71 | -23.44 | 34.84 | 21.71 | 10.39 | -9.92 | Upgrade |
Net Cash Flow | -203.9 | -723.81 | 92.57 | 1,643 | 1,340 | 1,425 | Upgrade |
Free Cash Flow | 3,669 | 3,052 | 4,412 | 3,102 | 2,590 | 2,450 | Upgrade |
Free Cash Flow Growth | 3.87% | -30.84% | 42.22% | 19.79% | 5.72% | 83.81% | Upgrade |
Free Cash Flow Margin | 16.72% | 14.54% | 21.66% | 19.26% | 17.27% | 20.57% | Upgrade |
Free Cash Flow Per Share | 0.40 | 0.33 | 0.48 | 0.34 | 0.29 | 0.28 | Upgrade |
Cash Income Tax Paid | 1,162 | 1,152 | 1,167 | 1,052 | 1,061 | 616.1 | Upgrade |
Levered Free Cash Flow | 2,517 | 2,580 | 3,107 | 2,611 | 3,045 | 2,137 | Upgrade |
Unlevered Free Cash Flow | 2,687 | 2,740 | 3,229 | 2,722 | 3,148 | 2,184 | Upgrade |
Change in Working Capital | -511.56 | -822.07 | -125.13 | -121.92 | -260.83 | 137.7 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.